'New drug combo shows promise against Covid'

Credit: IndiaTimes- Published on May 9, 2020
A two-week course of an antiviral therapy, started within seven days of experiencing Covid-19 symptoms, may improve clinical recovery of patients and reduce their hospital stay duration, according to the first randomised trial of this triple drug combination.The study, published in the journal The Lancet, involved 127 adults from...

Video credit: Wochit Entertainment
Published on May 8, 2020 -  00:34
Acute Respiratory Distress In COVID-19 Patients May Be Helped By Arthritis Med
A new study reveals a drug meant to treat rheumatoid arthritis may be of help to patients struggling to breathe due to the novel coronavirus. According to UPI, Anakinra has been used off-label to treat patients who developed acute respiratory distress syndrome caused by COVID-19. ARDS is the main cause of death from COVID-19. The drug is the latest prescription medication developed for another purpose to be evaluated for use in treating COVID-19.

You are here

Related videos from verified sources

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment 00:43
Credit: PA - Press Association STUDIO - Published 1 week ago 


Meharry doctor says COVID-19 drug stops virus from spreading 02:25
Credit: NewsChannel 5 Nashville - Published 2 weeks ago